+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Cancer Vaccines Global Market Report 2021: COVID-19 Growth and Change to 2030

  • ID: 5446044
  • Report
  • September 2021
  • Region: Global
  • 175 Pages
  • The Business Research Company

FEATURED COMPANIES

  • Aduro Biotech
  • Altor BioScience
  • Bavarian Nordic
  • Dendreon
  • Merck
  • Pfizer Inc.
Cancer Vaccines Global Market Report 2021: COVID-19 Growth and Change to 2030 provides the strategists, marketers and senior management with the critical information they need to assess the global cancer vaccines market.







This report focuses on the cancer vaccines market which is experiencing strong growth. The report gives a guide to the cancer vaccines market which will be shaping and changing our lives over the next ten years and beyond, including the market's response to the challenge of the global pandemic.

Reasons to Purchase


  • Gain a truly global perspective with the most comprehensive report available on this market covering 12+ geographies.
  • Understand how the market is being affected by the coronavirus and how it is likely to emerge and grow as the impact of the virus abates.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market research findings.
  • Benchmark performance against key competitors.
  • Utilize the relationships between key data sets for superior strategizing.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis

Description:


Where is the largest and fastest growing market for cancer vaccines? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The Cancer Vaccines market global report answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography. It places the market within the context of the wider cancer vaccines market, and compares it with other markets.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, the influence of the COVID-19 virus and forecasting its growth.
  • Market segmentations break down market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
  • Competitive landscape gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.
  • The cancer vaccines market section of the report gives context. It compares the cancer vaccines market with other segments of the cancer vaccines market by size and growth, historic and forecast. It analyses GDP proportion, expenditure per capita, cancer vaccines indicators comparison.

Scope


Markets Covered:


  • By Type: Preventive Cancer Vaccines; Therapeutic Cancer Vaccines
  • By Technology: Dendritic Cells (DC) Cancer Vaccines; Recombinant Cancer Vaccines; Antigen/Adjuvant Cancer Vaccines; Whole Cell Cancer Vaccines; Viral Vector & DNA Cancer Vaccines
  • By Cancer Type: Prostate; Cervical; Colorectal; Throat; Others
  • By End-User: Cancer Treatment Centers; Research Institutes

Companies Mentioned:


GlaxoSmithKline; Merck; Aduro Biotech; Astrazeneca Plc; Dendreon

Countries:


Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA

Regions:


Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa

Time Series:


Five years historic and ten years forecast.

Data:


Ratios of market size and growth to related markets, GDP proportions, expenditure per capita.

Data segmentations:


Country and regional historic and forecast data, market share of competitors, market segments.

Sourcing and Referencing:


Data and analysis throughout the report is sourced using end notes.


This product will be delivered within 1-3 business days.
Frequently Asked Questions about the Global Cancer Vaccines Market

What is the estimated value of the Global Cancer Vaccines Market?

The Global Cancer Vaccines Market was estimated to be valued at $5.6 billion in 2021.

What is the growth rate of the Global Cancer Vaccines Market?

The growth rate of the Global Cancer Vaccines Market is 13.4%, with an estimated value of $9.2 billion by 2025.

What is the forecasted size of the Global Cancer Vaccines Market?

The Global Cancer Vaccines Market is estimated to be worth $9.2 billion by 2025.

Who are the key companies in the Global Cancer Vaccines Market?

Key companies in the Global Cancer Vaccines Market include GlaxoSmithKline, Merck, Aduro Biotech, Astrazeneca Plc, Dendreon, Astellas Pharma Inc, Sanofi Pasteur, Sanpower Group and Pfizer Inc..
Note: Product cover images may vary from those shown

FEATURED COMPANIES

  • Aduro Biotech
  • Altor BioScience
  • Bavarian Nordic
  • Dendreon
  • Merck
  • Pfizer Inc.

1. Executive Summary2. Cancer Vaccines Market Characteristics3. Cancer Vaccines Market Trends and Strategies4. Impact Of COVID-19 On Cancer Vaccines
5. Cancer Vaccines Market Size and Growth
5.1. Global Cancer Vaccines Historic Market, 2015-2020, $ Billion
5.1.1. Drivers Of the Market
5.1.2. Restraints On the Market
5.2. Global Cancer Vaccines Forecast Market, 2020-2025F, 2030F, $ Billion
5.2.1. Drivers Of the Market
5.2.2. Restraints On the Market
6. Cancer Vaccines Market Segmentation
6.1. Global Cancer Vaccines Market, Segmentation by Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Preventive Cancer Vaccines
  • Therapeutic Cancer Vaccines
6.2. Global Cancer Vaccines Market, Segmentation by Technology, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Dendritic Cells (DC) Cancer Vaccines
  • Recombinant Cancer Vaccines
  • Antigen/Adjuvant Cancer Vaccines
  • Whole Cell Cancer Vaccines
  • Viral Vector & DNA Cancer Vaccines
6.3. Global Cancer Vaccines Market, Segmentation by Cancer Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Prostate
  • Cervical
  • Colorectal
  • Throat
  • Others
6.4. Global Cancer Vaccines Market, Segmentation by End-User, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Cancer Treatment Centers
  • Research Institutes

7. Cancer Vaccines Market Regional and Country Analysis
7.1. Global Cancer Vaccines Market, Split by Region, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
7.2. Global Cancer Vaccines Market, Split by Country, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
8. Asia-Pacific Cancer Vaccines Market
8.1. Asia-Pacific Cancer Vaccines Market Overview
  • Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
8.2. Asia-Pacific Cancer Vaccines Market, Segmentation by Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
8.3. Asia-Pacific Cancer Vaccines Market, Segmentation by Technology, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
9. China Cancer Vaccines Market
9.1. China Cancer Vaccines Market Overview
9.2. China Cancer Vaccines Market, Segmentation by Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F,$ Billion
9.3. China Cancer Vaccines Market, Segmentation by Technology, Historic and Forecast, 2015-2020, 2020-2025F, 2030F,$ Billion
10. India Cancer Vaccines Market
10.1. India Cancer Vaccines Market, Segmentation by Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
10.2. India Cancer Vaccines Market, Segmentation by Technology, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
11. Japan Cancer Vaccines Market
11.1. Japan Cancer Vaccines Market, Segmentation by Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
11.2. Japan Cancer Vaccines Market, Segmentation by Technology, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
12. Australia Cancer Vaccines Market
12.1. Australia Cancer Vaccines Market, Segmentation by Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
12.2. Australia Cancer Vaccines Market, Segmentation by Technology, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
13. Indonesia Cancer Vaccines Market
13.1. Indonesia Cancer Vaccines Market, Segmentation by Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
13.2. Indonesia Cancer Vaccines Market, Segmentation by Technology, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
14. South Korea Cancer Vaccines Market
14.1. South Korea Cancer Vaccines Market, Segmentation by Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
14.2. South Korea Cancer Vaccines Market, Segmentation by Technology, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
15. Western Europe Cancer Vaccines Market
15.1. Western Europe Cancer Vaccines Market Overview
15.2. Western Europe Cancer Vaccines Market, Segmentation by Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
15.3. Western Europe Cancer Vaccines Market, Segmentation by Technology, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
16. UK Cancer Vaccines Market
16.1. UK Cancer Vaccines Market, Segmentation by Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
16.2. UK Cancer Vaccines Market, Segmentation by Technology, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
17. Germany Cancer Vaccines Market
17.1. Germany Cancer Vaccines Market, Segmentation by Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
17.2. Germany Cancer Vaccines Market, Segmentation by Technology, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
18. France Cancer Vaccines Market
18.4. France Cancer Vaccines Market, Segmentation by Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
18.5. France Cancer Vaccines Market, Segmentation by Technology, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
19. Eastern Europe Cancer Vaccines Market
19.1. Eastern Europe Cancer Vaccines Market Overview
19.2. Eastern Europe Cancer Vaccines Market, Segmentation by Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
19.3. Eastern Europe Cancer Vaccines Market, Segmentation by Technology, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
20. Russia Cancer Vaccines Market
20.1. Russia Cancer Vaccines Market, Segmentation by Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
20.2. Russia Cancer Vaccines Market, Segmentation by Technology, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
21. North America Cancer Vaccines Market
21.1. North America Cancer Vaccines Market Overview
21.2. North America Cancer Vaccines Market, Segmentation by Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
21.3. North America Cancer Vaccines Market, Segmentation by Technology, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
22. USA Cancer Vaccines Market
22.1. USA Cancer Vaccines Market Overview
22.2. USA Cancer Vaccines Market, Segmentation by Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
22.3. USA Cancer Vaccines Market, Segmentation by Technology, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
23. South America Cancer Vaccines Market
23.1. South America Cancer Vaccines Market Overview
23.2. South America Cancer Vaccines Market, Segmentation by Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
23.3. South America Cancer Vaccines Market, Segmentation by Technology, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
24. Brazil Cancer Vaccines Market
24.1. Brazil Cancer Vaccines Market, Segmentation by Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
24.2. Brazil Cancer Vaccines Market, Segmentation by Technology, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
25. Middle East Cancer Vaccines Market
25.1. Middle East Cancer Vaccines Market Overview
25.2. Middle East Cancer Vaccines Market, Segmentation by Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
25.3. Middle East Cancer Vaccines Market, Segmentation by Technology, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
26. Africa Cancer Vaccines Market
26.1. Africa Cancer Vaccines Market Overview
26.2. Africa Cancer Vaccines Market, Segmentation by Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
26.3. Africa Cancer Vaccines Market, Segmentation by Technology, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
27. Cancer Vaccines Market Competitive Landscape and Company Profiles
27.1. Cancer Vaccines Market Competitive Landscape
27.2. Cancer Vaccines Market Company Profiles
27.2.1. GlaxoSmithKline
27.2.1.1. Overview
27.2.1.2. Products and Services
27.2.1.3. Strategy
27.2.1.4. Financial Performance
27.2.2. Merck
27.2.2.1. Overview
27.2.2.2. Products and Services
27.2.2.3. Strategy
27.2.2.4. Financial Performance
27.2.3. Aduro Biotech
27.2.3.1. Overview
27.2.3.2. Products and Services
27.2.3.3. Strategy
27.2.3.4. Financial Performance
27.2.4. Astrazeneca Plc
27.2.4.1. Overview
27.2.4.2. Products and Services
27.2.4.3. Strategy
27.2.4.4. Financial Performance
27.2.5. Dendreon
27.2.5.1. Overview
27.2.5.2. Products and Services
27.2.5.3. Strategy
27.2.5.4. Financial Performance
28. Cancer Vaccines Pipeline Analysis29. Key Mergers and Acquisitions in the Cancer Vaccines Market30. Cancer Vaccines Market Future Outlook and Potential Analysis
31. Appendix
31.1. Abbreviations
31.2. Currencies
31.3. Research Inquiries
31.4. About the Publisher
31.5. Copyright and Disclaimer
Note: Product cover images may vary from those shown

FEATURED COMPANIES

  • Aduro Biotech
  • Altor BioScience
  • Bavarian Nordic
  • Dendreon
  • Merck
  • Pfizer Inc.
Major players in the cancer vaccines market are, GlaxoSmithKline, Merck, Aduro Biotech, Astrazeneca Plc, Dendreon, Astellas Pharma Inc, Sanofi Pasteur, Sanpower Group, and CSL Limited.

The global cancer vaccines market is expected to grow from $4.9 billion in 2020 to $5.55 billion in 2021 at a compound annual growth rate (CAGR) of 13.3%. The growth is mainly due to the companies resuming their operations and adapting to the new normal while recovering from the COVID-19 impact, which had earlier led to restrictive containment measures involving social distancing, remote working, and the closure of commercial activities that resulted in operational challenges. The market is expected to reach $9.18 billion in 2025 at a CAGR of 13%.

The cancer vaccines market consists of sales of vaccines used for the treatment of cancers and related services by entities (organizations, sole traders and partnerships) that produce vaccines for cancer treatment. Cancer treatment vaccines, also called therapeutic vaccines are a type of immunotherapy, which stops tumor growth, destroys cancer cells and prevents the reoccurrence of cancers. The market consists of revenue generated by the company’s manufacturing cancer vaccines by the sales of these products.

The cancer vaccines market covered in this report is segmented by type into preventive cancer vaccines, therapeutic cancer vaccines. It is also segmented by technology into dendritic cells (DC) cancer vaccines, recombinant cancer vaccines, antigen/adjuvant cancer vaccines, whole cell cancer vaccines, viral vector & DNA cancer vaccines, by cancer type into prostate, cervical, colorectal, throat, others and by end-user into cancer treatment centers, research institutes.

The regions covered in this report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

Alternative treatment methods and natural remedies are increasingly becoming popular globally and this is expected to have a negative impact on the revenues of cancer vaccines manufacturing companies. Treatments in the fields of homeopathy, Ayurveda, yoga, acupuncture, sujok therapy are gaining popularity and slowly replacing some traditional hospital practices. For instance, Ayurvedic medicine, an ancient Indian system of medicine uses a range of techniques and treatments for cancer. According to the World Health Organization (WHO), some nations are still responding to plant-based treatment as their main medicine source and developing nations are using the benefits of natural compounds for therapeutic purposes, which is affecting the cancer vaccine sales. Also, the global homeopathic product market is projected to reach $18.6 billion by the end of 2027. This trend is expected to continue during the forecast period and limit the demand for cancer vaccines.

In May 2020, Merck, a US-based pharmaceutical company, acquired Themis Bioscience for an undisclosed amount. The acquisition is expected to complement Merck's capabilities in the development, manufacturing, and distribution of vaccines. Themis Bioscience is a pharmaceutical company that manufactures vaccines and immune-modulatory therapies developed using the measles virus vector platform based on a vector originally.

The rise in the number of cancer cases across the globe is likely to contribute to the growth of the cancer vaccines market during the forecast period. According to the American Cancer Society, there were 1,7 million new cases and 0.6 million cancer deaths in 2019 in the USA. The four most common types of cancer worldwide are lung, prostate, bowel, and female breast cancer, accounting for 43% of all the new cancer cases. Therefore, the rise in cancer incidence rate globally is anticipated to boost the demand for the cancer vaccines market over the coming years.

Companies in the cancer vaccines market are increasingly investing in preventive or prophylactic vaccines for cancer prevention. Prophylactic vaccines are designed to build immunity in a patient. A prophylactic or preventative vaccine involves introducing antigens into a person's body. According to the World Health Organization, cervical cancer was reported as the second-most common cancer in women with an estimation of 84% new cases worldwide. So far, there are 3 HPV vaccines currently present for the prophylaxis of cancers. Two among these will protect against both HPV 16 and HPV 18, which causes 70% of cervical cancer and the third vaccine prevents 3 more oncogenic HPV types, which further causes 20% of cervical cancers. These three vaccines include Gardasil and Gardasil9 by Merck and Cervarix by GSK. In April 2019, Bayer, through its investment arm Leaps by Bayer, has invested in a US-based biotechnology firm Khloris Biosciences, which is focused on developing prophylactic anti-cancer vaccines.

The countries covered in the market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA.
Note: Product cover images may vary from those shown

A selection of companies mentioned in this report includes:

  • GlaxoSmithKline
  • Merck
  • Aduro Biotech
  • Astrazeneca Plc
  • Dendreon
  • Astellas Pharma Inc
  • Sanofi Pasteur
  • Sanpower Group
  • CSL Limited
  • Pfizer Inc.
  • Serum Institute of India Pvt. Ltd
  • Advantagene
  • Advaxis
  • Agenus
  • Altor BioScience
  • Argos Therapeutics
  • OncoThyreon
  • Oncovir
  • Oxford BioMedica
  • Prsima BioMed
  • Sotio
  • Transgene
  • Ubivac
  • Vaccinogen and Vaxon Biotech
  • Bavarian Nordic
  • Bharat Biotech
  • Bristol-Myers Squibb
  • Dynavax Technologies Corporation
  • Emergent Biosolutions
  • Galena Biopharma
Note: Product cover images may vary from those shown

Loading
LOADING...